Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life (Q35455334)

8 August 2017

title

Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life (English)

1 reference

cost-effectiveness analysis

8 August 2017

0 references

1 reference

D Parkin

1

1 reference

8 August 2017

A Jacoby

2

1 reference

8 August 2017

P McNamee

3

1 reference

8 August 2017

P Miller

4

1 reference

8 August 2017

S Thomas

5

1 reference

8 August 2017

D Bates

6

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

8 August 2017

published in

1 reference

8 August 2017

volume

68

1 reference

8 August 2017

issue

2

1 reference

8 August 2017

page(s)

144-149

1 reference

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

Short form 36 (SF36) health survey questionnaire: normative data for adults of working age

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

The MOS 36-ltem Short-Form Health Survey (SF-36)

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1736797

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

12 July 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10644777

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP.68.2.144

1 reference

8 August 2017

1 reference

8 August 2017

1 reference